Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT
Clinical trial NCT02452697 · UNKNOWN
Trial details
- NCT number
- NCT02452697
- Sponsor
- Cristina Gasparetto
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-08
- Primary completion
- 2022-07-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.